A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study To Assess The Efficacy, Safety And Tolerability of PF-04950615 Following Multiple Intravenous Doses In Hypercholesterolemic Subjects On Maximum Dose Of Atorvastatin Or Rosuvastatin.
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2012
At a glance
- Drugs Bococizumab (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 30 Jul 2012 Actual initiation date changed from 1 Jul 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 30 Jul 2012 Actual end date (1 Jun 2012) added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Planned end date changed from 1 Jun 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.